Heterogeneous Response of Airway Eosinophilia to Anti-IL-5 Biologics in Severe Asthma Patients

Many questions concerning responders (R) and nonresponders (NR) in severe eosinophilic asthma (SEA) after blocking the IL-5 (interleukin 5) pathway are still not clear, especially regarding the early parameters of response to biologics in personalized treatment strategies. We evaluated 17 SEA patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Šokić, Maruša Kopač, Rijavec, Matija, Korošec, Peter, Bidovec-Stojkovič, Urška, Kern, Izidor, Vantur, Romana, Škrgat, Sabina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781789/
https://www.ncbi.nlm.nih.gov/pubmed/35055384
http://dx.doi.org/10.3390/jpm12010070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781789/
https://www.ncbi.nlm.nih.gov/pubmed/35055384
http://dx.doi.org/10.3390/jpm12010070

Ejemplares similares